Literature DB >> 6163536

Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.

T Kataoka, Y Sakurai, N Ida, S Kobayashi.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6163536     DOI： 10.1016/s0305-7372(80)80043-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

Review 1.  Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Authors:  K Teelmann; C Hohbach; H Lehmann
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

2.  Characteristics of in vitro antiproliferation activity of human interferon-beta.

Authors:  T Kataoka; F Oh-hashi; Y Sakurai; N Ida
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Establishment and characterization of a human cell strain, KT, with high sensitivity to UV-killing and to cell proliferation inhibition by interferon.

Authors:  N Suzuki; N Inaba; I Sugano; S Umehara; T Murakami; Y Takakubo
Journal:  Jpn J Cancer Res       Date:  1988-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.